TMPRSS6 and IRIDA syndrome: This could assist clinicians with referring patients suspected of having IRIDA for TMPRSS6 analysis in a timely manner so that they can benefit from early initiation of effective treatment (usually IV iron therapy) after IRIDA has been confirmed by the presence of biallelic or monoallelic pathogenic TMPRSS6 variants.